| HGNC Family | Non-coding RNAs |
| Name | microRNA 622 |
| Description | microRNAs (miRNAs) are short (20-24 nt) non-coding RNAs that are involved in post-transcriptional regulation of gene expression in multicellular organisms by affecting both the stability and translation of mRNAs. miRNAs are transcribed by RNA polymerase II as part of capped and polyadenylated primary transcripts (pri-miRNAs) that can be either protein-coding or non-coding. The primary transcript is cleaved by the Drosha ribonuclease III enzyme to produce an approximately 70-nt stem-loop precursor miRNA (pre-miRNA), which is further cleaved by the cytoplasmic Dicer ribonuclease to generate the mature miRNA and antisense miRNA star (miRNA*) products. The mature miRNA is incorporated into a RNA-induced silencing complex (RISC), which recognizes target mRNAs through imperfect base pairing with the miRNA and most commonly results in translational inhibition or destabilization of the target mRNA. The RefSeq represents the predicted microRNA stem-loop. [provided by RefSeq, Sep 2009] |
| Summary |
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nMicroRNA‐622 has emerged as a potent tumor suppressor that is frequently downregulated in a variety of human malignancies. Multiple independent studies have reported that lower miR‐622 levels correlate with aggressive clinical features and poor patient outcomes in cancers such as gastric cancer, lung cancer, gliomas, colorectal cancer, hepatocellular carcinoma, esophageal squamous cell carcinoma, melanoma, and prostate cancer. Restoration of miR‐622 expression has been shown to inhibit cell proliferation, migration, invasion, angiogenesis, colony formation, and even to induce apoptosis and cell cycle arrest, thereby impairing tumorigenesis and metastatic progression."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "14"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nMechanistically, miR‐622 exerts its function by directly binding to the 3′ untranslated regions of key oncogenic transcripts, thereby repressing their expression. For instance, miR‐622 directly targets CXCR4 to modulate cell–cell signaling and angiogenesis in hepatocellular and colorectal cancers, and it inhibits the expression of KRAS in lung cancer, colorectal cancer, glioblastoma, melanoma, and prostate cancer. Additional studies have identified MAP4K4, ATF2, YAP1, LIN28A with its co‐operator ZCCHC11, and NUAK1 as direct targets, linking miR‐622 to the regulation of diverse mitogenic and pro‐survival signaling cascades such as the ERK, JNK, NF‐κB, and JAK1/STAT3 pathways. Furthermore, regulatory axes involving noncoding RNAs—including interference by long noncoding RNAs like KCNQ1OT1 and circular RNAs such as hsa‐circ‐0000211 and SAMMSON that act as molecular sponges for miR‐622—add additional layers of control over its tumor‐suppressive functions."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "2", "end_ref": "8"}, {"type": "fg_f", "ref": "10"}, {"type": "fg_fs", "start_ref": "15", "end_ref": "20"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nCollectively, these findings highlight the central role of miR‐622 as an important molecular brake in tumor development and progression. Its downregulation across multiple cancer types unleashes oncogenic signaling networks that drive proliferation, metastasis, and angiogenesis. Accordingly, therapeutic strategies aimed at restoring miR‐622 levels or disrupting its interactions with oncogenic targets may have significant clinical potential. This is further supported by ongoing efforts to delineate its interactions with coding and noncoding RNAs, which offer promising avenues for biomarker development and targeted therapy in malignancies such as esophageal, cholangiocarcinoma, and breast cancers."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}, {"type": "fg_f", "ref": "9"}, {"type": "fg_f", "ref": "21"}, {"type": "fg_fs", "start_ref": "12", "end_ref": "14"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Xiao-Bo Guo, Chang-Qing Jing, Le-Ping Li, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Down-regulation of miR-622 in gastric cancer promotes cellular invasion and tumor metastasis by targeting ING1 gene."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "World J Gastroenterol (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3748/wjg.v17.i14.1895"}], "href": "https://doi.org/10.3748/wjg.v17.i14.1895"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21528065"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21528065"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Zhiyuan Han, Qiaoyuan Yang, Binbin Liu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-622 functions as a tumor suppressor by targeting K-Ras and enhancing the anticarcinogenic effect of resveratrol."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Carcinogenesis (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/carcin/bgr226"}], "href": "https://doi.org/10.1093/carcin/bgr226"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22016468"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22016468"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Rui Zhang, Hui Luo, Shuai Wang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MiR-622 suppresses proliferation, invasion and migration by directly targeting activating transcription factor 2 in glioma cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Neurooncol (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s11060-014-1607-y"}], "href": "https://doi.org/10.1007/s11060-014-1607-y"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25258251"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25258251"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Yantian Fang, Bo Sun, Zhenyang Li, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MiR-622 inhibited colorectal cancer occurrence and metastasis by suppressing K-Ras."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Carcinog (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/mc.22380"}], "href": "https://doi.org/10.1002/mc.22380"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26333174"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26333174"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Haiou Liu, Yidong Liu, Weisi Liu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "EZH2-mediated loss of miR-622 determines CXCR4 activation in hepatocellular carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Commun (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/ncomms9494"}], "href": "https://doi.org/10.1038/ncomms9494"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26404566"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26404566"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Wei-Hua Song, Xiao-Jun Feng, Shao-Juan Gong, et al. "}, {"type": "b", "children": [{"type": "t", "text": "microRNA-622 acts as a tumor suppressor in hepatocellular carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Biol Ther (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1080/15384047.2015.1095402"}], "href": "https://doi.org/10.1080/15384047.2015.1095402"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26467022"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26467022"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Chun-Wen Cheng, Po-Ming Chen, Yi-Hsien Hsieh, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Foxo3a-mediated overexpression of microRNA-622 suppresses tumor metastasis by repressing hypoxia-inducible factor-1α in ERK-responsive lung cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncotarget (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.18632/oncotarget.5826"}], "href": "https://doi.org/10.18632/oncotarget.5826"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26528854"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26528854"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Xinzhi Wang, Zhenxue Xin, Yinfu Xu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Upregulated miRNA-622 inhibited cell proliferation, motility, and invasion via repressing Kirsten rat sarcoma in glioblastoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Tumour Biol (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s13277-015-4455-2"}], "href": "https://doi.org/10.1007/s13277-015-4455-2"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26596833"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26596833"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Changshan Song, Pingfang Lu, Weicheng Shi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MiR-622 functions as a tumor suppressor and directly targets E2F1 in human esophageal squamous cell carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biomed Pharmacother (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.biopha.2016.07.036"}], "href": "https://doi.org/10.1016/j.biopha.2016.07.036"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27501502"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27501502"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Jin Xu, Banyou Ma, Gong Chen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-622 suppresses the proliferation of glioma cells by targeting YAP1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Cell Biochem (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/jcb.26343"}], "href": "https://doi.org/10.1002/jcb.26343"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28796324"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28796324"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Peter Dietrich, Silke Kuphal, Thilo Spruss, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-622 is a novel mediator of tumorigenicity in melanoma by targeting Kirsten rat sarcoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Pigment Cell Melanoma Res (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/pcmr.12698"}], "href": "https://doi.org/10.1111/pcmr.12698"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29495114"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29495114"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Niloufar Targhazeh, Bahman Yousefi, Samira Asghari, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MiR-622 acts as a tumor suppressor to induce cell apoptosis and inhibit metastasis in human prostate cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Andrologia (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/and.14174"}], "href": "https://doi.org/10.1111/and.14174"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34231241"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34231241"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "Juan Lu, Zhongyang Xie, Zhaoying Xiao, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The expression and function of miR-622 in a variety of tumors."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biomed Pharmacother (2022)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.biopha.2021.112544"}], "href": "https://doi.org/10.1016/j.biopha.2021.112544"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34929578"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34929578"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Jian Yang, Jian Lu, Ni Yin, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-622 Counteracts the NUAK1-Induced Gastric Cancer Cell Proliferation and the Antioxidative Stress."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Dis Markers (2022)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1155/2022/9616764"}], "href": "https://doi.org/10.1155/2022/9616764"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "35872695"}], "href": "https://pubmed.ncbi.nlm.nih.gov/35872695"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "Y Zhang, A Liu, M E, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Three novel microRNAs based on microRNA signatures for gastric mucosa-associated lymphoid tissue lymphoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Neoplasma (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.4149/neo_2018_170208N89"}], "href": "https://doi.org/10.4149/neo_2018_170208N89"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29788729"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29788729"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "Yantian Fang, Bo Sun, Jiangli Wang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-622 inhibits angiogenesis by suppressing the CXCR4-VEGFA axis in colorectal cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Gene (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.gene.2019.03.004"}], "href": "https://doi.org/10.1016/j.gene.2019.03.004"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30851425"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30851425"}]}, {"type": "r", "ref": 17, "children": [{"type": "t", "text": "Jingwei Xie, Xinjun Wang, Shanshan Liu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "LncRNA SAMMSON overexpression distinguished glioblastoma patients from patients with diffuse neurosarcoidosis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Neuroreport (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1097/WNR.0000000000001278"}], "href": "https://doi.org/10.1097/WNR.0000000000001278"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31283714"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31283714"}]}, {"type": "r", "ref": 18, "children": [{"type": "t", "text": "Dongjie Feng, Youtao Xu, Jingwen Hu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A novel circular RNA, hsa-circ-0000211, promotes lung adenocarcinoma migration and invasion through sponging of hsa-miR-622 and modulating HIF1-α expression."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochem Biophys Res Commun (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bbrc.2019.10.134"}], "href": "https://doi.org/10.1016/j.bbrc.2019.10.134"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31668923"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31668923"}]}, {"type": "r", "ref": 19, "children": [{"type": "t", "text": "Francesca Maria Orlandella, Raffaela Mariarosaria Mariniello, Peppino Mirabelli, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-622 is a novel potential biomarker of breast carcinoma and impairs motility of breast cancer cells through targeting NUAK1 kinase."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Br J Cancer (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41416-020-0884-9"}], "href": "https://doi.org/10.1038/s41416-020-0884-9"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32418991"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32418991"}]}, {"type": "r", "ref": 20, "children": [{"type": "t", "text": "Anne Gaza, Valerie Fritz, Lara Malek, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Identification of novel targets of miR-622 in hepatocellular carcinoma reveals common regulation of cooperating genes and outlines the oncogenic role of zinc finger CCHC-type containing 11."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Neoplasia (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.neo.2021.04.001"}], "href": "https://doi.org/10.1016/j.neo.2021.04.001"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33901943"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33901943"}]}, {"type": "r", "ref": 21, "children": [{"type": "t", "text": "Yi-Fei Wu, Zhuo-Ri Li, Zhi-Qi Cheng, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Decrease of miR-622 expression promoted the proliferation, migration and invasion of cholangiocarcinoma cells by targeting regulation of c-Myc."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biomed Pharmacother (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.biopha.2017.09.043"}], "href": "https://doi.org/10.1016/j.biopha.2017.09.043"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28961507"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28961507"}]}]}]}
|
| Synonyms | HSA-MIR-622, MIRN622 |
| NCBI Gene ID | 693207 |
| API | |
| Download Associations | |
| Predicted Functions |
![]() |
| Co-expressed Genes |
![]() |
| Expression in Tissues and Cell Lines |
![]() |
MIR622 has 388 functional associations with biological entities spanning 6 categories (molecular profile, chemical, disease, phenotype or trait, functional term, phrase or reference, cell line, cell type or tissue, gene, protein or microRNA) extracted from 20 datasets.
Click the + buttons to view associations for MIR622 from the datasets below.
If available, associations are ranked by standardized value
| Dataset | Summary | |
|---|---|---|
| BioGPS Cell Line Gene Expression Profiles | cell lines with high or low expression of MIR622 gene relative to other cell lines from the BioGPS Cell Line Gene Expression Profiles dataset. | |
| BioGPS Human Cell Type and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of MIR622 gene relative to other cell types and tissues from the BioGPS Human Cell Type and Tissue Gene Expression Profiles dataset. | |
| CCLE Cell Line Gene CNV Profiles | cell lines with high or low copy number of MIR622 gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset. | |
| ChEA Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of MIR622 gene from the CHEA Transcription Factor Binding Site Profiles dataset. | |
| ChEA Transcription Factor Targets | transcription factors binding the promoter of MIR622 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets dataset. | |
| CMAP Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of MIR622 gene from the CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| COSMIC Cell Line Gene CNV Profiles | cell lines with high or low copy number of MIR622 gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset. | |
| CTD Gene-Disease Associations | diseases associated with MIR622 gene/protein from the curated CTD Gene-Disease Associations dataset. | |
| ENCODE Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at MIR622 gene from the ENCODE Histone Modification Site Profiles dataset. | |
| ENCODE Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of MIR622 gene from the ENCODE Transcription Factor Binding Site Profiles dataset. | |
| ENCODE Transcription Factor Targets | transcription factors binding the promoter of MIR622 gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset. | |
| GeneRIF Biological Term Annotations | biological terms co-occuring with MIR622 gene in literature-supported statements describing functions of genes from the GeneRIF Biological Term Annotations dataset. | |
| GeneSigDB Published Gene Signatures | PubMedIDs of publications reporting gene signatures containing MIR622 from the GeneSigDB Published Gene Signatures dataset. | |
| GEO Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of MIR622 gene from the GEO Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations | transcription factor perturbations changing expression of MIR622 gene from the GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations dataset. | |
| JASPAR Predicted Transcription Factor Targets | transcription factors regulating expression of MIR622 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Transcription Factor Targets dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles | cell lines with high or low copy number of MIR622 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset. | |
| KnockTF Gene Expression Profiles with Transcription Factor Perturbations | transcription factor perturbations changing expression of MIR622 gene from the KnockTF Gene Expression Profiles with Transcription Factor Perturbations dataset. | |
| MotifMap Predicted Transcription Factor Targets | transcription factors regulating expression of MIR622 gene predicted using known transcription factor binding site motifs from the MotifMap Predicted Transcription Factor Targets dataset. | |
| Roadmap Epigenomics Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at MIR622 gene from the Roadmap Epigenomics Histone Modification Site Profiles dataset. | |